Bioconjugation & ADC Development Expertise
Aqura Bio. supports the design, synthesis, and optimisation of antibody–drug conjugates (ADCs), conjugated oligonucleotides, and protein tagging technologies.
Combining advanced linker chemistry, precision conjugation techniques, and AI-assisted process development, we help researchers create stable, scalable bioconjugates that maintain biological activity and improve therapeutic performance. Our integrated approach bridges early discovery and preclinical development, enabling faster progression from concept to candidate.
Whether developing targeted biologics, next-generation drug delivery systems, or novel hybrid molecules, Aqura Bio. provides the expertise and innovation to accelerate your bioconjugation research.
Contact Us
Discuss your next project with us and see how we can create the compounds you need.